Literature DB >> 18363678

Consensus list of signals to detect potential adverse drug reactions in nursing homes.

Steven M Handler1, Joseph T Hanlon, Subashan Perera, Yazan F Roumani, David A Nace, Douglas B Fridsma, Melissa I Saul, Nicholas G Castle, Stephanie A Studenski.   

Abstract

OBJECTIVES: To develop a consensus list of agreed-upon laboratory, pharmacy, and Minimum Data Set signals that a computer system can use in the nursing home to detect potential adverse drug reactions (ADRs).
DESIGN: Literature search for potential ADR signals, followed by an internet-based, a two-round, modified Delphi survey.
SETTING: A nationally representative survey of experts in geriatrics. PARTICIPANTS: Panel of 13 physicians, 10 pharmacists, and 13 advanced practitioners. MEASUREMENTS: Mean score and 95% confidence interval (CI) for each of 80 signals rated on a 5-point Likert scale (5=strong agreement with likelihood of indicating potential ADRs). Consensus agreement indicated by a lower-limit 95% CI of 4.0 or greater.
RESULTS: Panelists reached consensus agreement on 40 signals: 15 laboratory and medication combinations, 12 medication concentrations, 10 antidotes, and three Resident Assessment Protocols (RAPs). Highest consensus scores (4.6, 95% CI=4.4-4.9 or 4.4-4.8) were for naloxone when taking opioid analgesics; phytonadione when taking warfarin; dextrose, glucagon, or liquid glucose when taking hypoglycemic agents; medication-induced hypoglycemia; supratherapeutic international normalized ratio when taking warfarin; and triggering the Falls RAP when taking certain medications.
CONCLUSION: A multidisciplinary expert panel was able to reach consensus agreement on a list of signals to detect potential ADRs in nursing home residents. The results of this study can be used to prioritize an initial list of signals to be included in paper- or computer-based methods for potential ADR detection.

Entities:  

Mesh:

Year:  2008        PMID: 18363678      PMCID: PMC2695658          DOI: 10.1111/j.1532-5415.2008.01665.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  33 in total

1.  Incidence and preventability of adverse drug events in nursing homes.

Authors:  J H Gurwitz; T S Field; J Avorn; D McCormick; S Jain; M Eckler; M Benser; A C Edmondson; D W Bates
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

2.  Methodology and rationale for the measurement of harm with trigger tools.

Authors:  R K Resar; J D Rozich; D Classen
Journal:  Qual Saf Health Care       Date:  2003-12

3.  Medication error reporting in long term care.

Authors:  Steven M Handler; David A Nace; Stephanie A Studenski; Douglas B Fridsma
Journal:  Am J Geriatr Pharmacother       Date:  2004-09

4.  The incidence of adverse drug events in two large academic long-term care facilities.

Authors:  Jerry H Gurwitz; Terry S Field; James Judge; Paula Rochon; Leslie R Harrold; Cynthia Cadoret; Monica Lee; Kathleen White; Jane LaPrino; Janet Erramuspe-Mainard; Martin DeFlorio; Linda Gavendo; Jill Auger; David W Bates
Journal:  Am J Med       Date:  2005-03       Impact factor: 4.965

5.  Functional gaps in attaining a national health information network.

Authors:  Rainu Kaushal; David W Bates; Eric G Poon; Ashish K Jha; David Blumenthal
Journal:  Health Aff (Millwood)       Date:  2005 Sep-Oct       Impact factor: 6.301

Review 6.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

7.  The costs of a national health information network.

Authors:  Rainu Kaushal; David Blumenthal; Eric G Poon; Ashish K Jha; Calvin Franz; Blackford Middleton; John Glaser; Gilad Kuperman; Melissa Christino; Rushika Fernandopulle; Joseph P Newhouse; David W Bates
Journal:  Ann Intern Med       Date:  2005-08-02       Impact factor: 25.391

8.  Monitoring of drugs with a narrow therapeutic range in ambulatory care.

Authors:  Marsha A Raebel; Nikki M Carroll; Susan E Andrade; Elizabeth A Chester; Jennifer Elston Lafata; Adrianne Feldstein; Margaret J Gunter; Winnie W Nelson; Steven R Simon; K Arnold Chan; Robert L Davis; Richard Platt
Journal:  Am J Manag Care       Date:  2006-05       Impact factor: 2.229

9.  Adverse drug event trigger tool: a practical methodology for measuring medication related harm.

Authors:  J D Rozich; C R Haraden; R K Resar
Journal:  Qual Saf Health Care       Date:  2003-06

10.  Preventing drug-related morbidity--the development of quality indicators.

Authors:  C J Morris; J A Cantrill
Journal:  J Clin Pharm Ther       Date:  2003-08       Impact factor: 2.512

View more
  24 in total

1.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

2.  What is nursing home quality and how is it measured?

Authors:  Nicholas G Castle; Jamie C Ferguson
Journal:  Gerontologist       Date:  2010-07-14

3.  Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home.

Authors:  Steven M Handler; Joseph T Hanlon; Subashan Perera; Melissa I Saul; Douglas B Fridsma; Shyam Visweswaran; Stephanie A Studenski; Yazan F Roumani; Nicholas G Castle; David A Nace; Michael J Becich
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

4.  Development and initial validation of a content taxonomy for patient records in general dentistry.

Authors:  Amit Acharya; Pedro Hernandez; Thankam Thyvalikakath; Harold Ye; Mei Song; Titus Schleyer
Journal:  Int J Med Inform       Date:  2013-07-06       Impact factor: 4.046

5.  A survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferences.

Authors:  R D Boyce; S Perera; D A Nace; C M Culley; S M Handler
Journal:  Appl Clin Inform       Date:  2014-10-29       Impact factor: 2.342

6.  Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.

Authors:  Daniel Sevilla-Sanchez; Núria Molist-Brunet; Jordi Amblàs-Novellas; Pere Roura-Poch; Joan Espaulella-Panicot; Carles Codina-Jané
Journal:  Eur J Clin Pharmacol       Date:  2016-10-04       Impact factor: 2.953

7.  Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.

Authors:  Guillaume Hébert; Florence Netzer; Sylvain Landry Kouakou; François Lemare; Etienne Minvielle
Journal:  Int J Clin Pharm       Date:  2018-02-14

8.  Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Authors:  Kate L Lapane; Carmel M Hughes; Lori A Daiello; Kathleen A Cameron; Janice Feinberg
Journal:  J Am Geriatr Soc       Date:  2011-06-07       Impact factor: 5.562

9.  Consensus guidelines for oral dosing of primarily renally cleared medications in older adults.

Authors:  Joseph T Hanlon; Sherrie L Aspinall; Todd P Semla; Steven D Weisbord; Linda F Fried; C Bernie Good; Michael J Fine; Roslyn A Stone; Mary Jo V Pugh; Michelle I Rossi; Steven M Handler
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

10.  [Drug therapy in the elderly :what are the problems? What are the dos and don'ts?].

Authors:  H K Berthold; E Steinhagen-Thiessen
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.